Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test, ThyGenX, an expanded oncogenic mutation panel that helps identify malignant thyroid nodules, ThyraMIR, which assesses thyroid nodules for risk of malignancy, and RespriDx, a genomic test that helps physicians differentiate metastatic or recurrent lung cancer. The company was founded by John P. Dugan in 1986 and is headquartered in Parsippany, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
111
Frequently Asked Questions
What is Market Cap of Interpace Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Interpace Biosciences Inc market cap is $4.03M.
What is the 52-week high for Interpace Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Interpace Biosciences Inc 52 week high is $3.54 as of September 17, 2025.
What is the 52-week low for Interpace Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Interpace Biosciences Inc 52 week low is $0.4433 as of September 17, 2025.
What is Interpace Biosciences Inc stock price today?
Interpace Biosciences Inc stock price today is $0.91.
What was Interpace Biosciences Inc stock price yesterday?
Interpace Biosciences Inc stock price yesterday was $0.85.
What is the PE ratio of Interpace Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Interpace Biosciences Inc’s P/E ratio is 1.73.
What is the Price-to-Book ratio of Interpace Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Interpace Biosciences Inc P/B ratio is -3.3183.
What is the 50-day moving average of Interpace Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Interpace Biosciences Inc 50-day moving average is $0.8729.
How many employess does Interpace Biosciences Inc has?
